• Connect with us
    • Information
      • About Us
      • Contact Us
      • Careers
      • Partnerships
      • Advertise With Us
      • Authors
      • Browse Topics
      • Events
      • Disclaimer
      • Privacy Policy
    • Australia
      North America
      World
    Login
    Investing News NetworkYour trusted source for investing success
    • North America
      Australia
      World
    • My INN
    Videos
    Companies
    Press Releases
    Private Placements
    SUBSCRIBE
    • Reports & Guides
      • Market Outlook Reports
      • Investing Guides
    • Button
    Resource
    • Precious Metals
    • Battery Metals
    • Base Metals
    • Energy
    • Critical Metals
    Tech
    Life Science
    Company Market
    Company News
    Company Stocks
    • Company Market
    • Company News
    • Company Stocks
    cannabis investing

    Aurora Completes $15 Million Debenture Offering

    Pia Rivera
    Sep. 28, 2016 11:12AM PST
    Company News

    Aurora Cannabis Inc. (CSE:ACB,OTCQB:ACBFF) has completed the brokered private placement of 10.0% unsecured convertible debentures of the Company with Canaccord Genuity Corp. for gross proceeds of $15 million.

    Aurora Cannabis Inc. (CSE:ACB,OTCQB:ACBFF) has completed the brokered private placement of 10.0% unsecured convertible debentures of the Company with Canaccord Genuity Corp. for gross proceeds of $15 million.
    As quoted in the press release:

    Pursuant to an enhanced finance strategy, the Company is leveraging a portion of the Debentures to immediately improve its balance sheet and replace $4 million of high interest and senior secured debt. Furthermore, certain onerous debt covenants and compliance reporting have now been eliminated.
    “This financing provides Aurora with additional financial flexibility and a significantly improved balance sheet, and enables us to further increase our focus on reaching profitability and building long-term shareholder value”, said Terry Booth, Aurora’s Chief Executive Officer. “With an improved working capital position and increasing revenues, Aurora continues to strengthen our financial foundation as we enter a pivotal and exciting period in the development of the cannabis sector.”
    The Debentures are unsecured obligations of the Company and bear interest from the date of closing at 10.0% per annum, payable semi-annually on June 30 and December 31 of each year. The Debentures will mature on March 28 2018 (the “Maturity Date”).
    The Debentures are convertible at the option of the holder into common shares of the Company at any time prior to the close of business on the Maturity Date, at a conversion price of $1.15 per common share (the “Conversion Price”). Holders converting their Debentures will receive accrued and unpaid interest thereon, up to, but excluding, the date of conversion.

    private placementcannabis investingcannabis inc
    The Conversation (0)

    Go Deeper

    AI Powered
    Aurora Cannabis Completes Balance Sheet Restructuring

    Aurora Cannabis Completes Balance Sheet Restructuring

    Cannabis Investing

    Harvest One Announces $15 Million Bought Short form Prospectus Offering of Convertible Debenture Units

    Latest News

    Outlook Reports

    Resource
    • Precious Metals
      • Gold
      • Silver
    • Battery Metals
      • Lithium
      • Cobalt
      • Graphite
    • Energy
      • Uranium
      • Oil and Gas
    • Base Metals
      • Copper
      • Nickel
      • Zinc
    • Critical Metals
      • Rare Earths
    • Industrial Metals
    • Agriculture
    Tech
      • Artificial Intelligence
      • Cybersecurity
      • Gaming
      • Cleantech
      • Emerging Tech
    Life Science
      • Biotech
      • Cannabis
      • Psychedelics
      • Pharmaceuticals

    Featured Stocks

    extractX

    Adastra Holdings

    XTRX:CNX

    AgriFORCE Growing Systems

    AGRI

    4Front Ventures

    FFNT:CNX
    More featured stocks

    Browse Companies

    Resource
    • Precious Metals
    • Battery Metals
    • Energy
    • Base Metals
    • Critical Metals
    Tech
    Life Science
    MARKETS
    COMMODITIES
    CURRENCIES
    ×